Engxenyeni yokuqala ka-2022, ukuthunyelwa kwemikhiqizo yezempilo efana nomuthi waseKorea, imishini yezokwelapha kanye nezimonyo kanye nezimonyo kufinyelela irekhodi eliphakeme. I-COVIAL-19 Ukuxilonga reagents kanye nemithi yokugomela ukuthunyelwa kwamanye amazwe.
Ngokusho kweKorea Health Industry Development Institute (Khidi), ukuthunyelwa kwamanye amazwe imboni kufinyelela ama- $ 13.35 billion engxenyeni yokuqala yalo nyaka. Leso sibalo sasikhuphuke 8.5% kusuka ku- $ 12,3 billion ngonyaka owedlule futhi saba ngumphumela ophakeme kunabo bonke. Kubhalwe ngaphezulu kwama- $ 13.15 billion engxenyeni yesibili ka-2021.
Ngomkhakha, ukuthunyelwa kwamakhambi kwacelwa ama-US $ 4.35 billion, up 45.0% kusuka ku-US $ 3.0 billion ngesikhathi esifanayo ngo-2021. Ukuthengiswa kwamathuluzi ezokwelapha kube yi-USD 4.93 billion, up 5.2% unyaka ngonyaka. Ngenxa ye-Quararine eChina, izimonyo zokuthumela ngaphandle kwawe ngo-11.9% kuya ku- $ 4.06 billion.
Ukukhula kokuthumela ngaphandle kwemithi kuqhutshwa yi-biopharmaceuticals kanye nemijovo. Ukuthekelisa kwama-biofarmaceuticals kufinyelele kuma- $ 1.68 billion, kuyilapho ukuthekelisa imigomo kufinyelela kuma- $ 780 million. Zombili zibalelwa ku-56.4% wazo zonke izinto zokuthumela ezenza ngemithi. Ikakhulu, ukuthunyelwa kwamanye amazwe okugoma kwanda ngo-490.8% ngonyaka ngenxa yokwanda kokukhishwa kwamanye amazwe kwemigomo yokugoma i-19 ekhiqizwa ngaphansi kokukhiqiza inkontileka.
Emkhakheni wamadivayisi wezokwelapha, i-akhawunti yokuxilonga i-reagegents yesabelo esikhulu kunazo zonke, ifinyelela ama- $ 2.48 billion, up 2.8% kusuka esikhathini esifanayo ngo-2021. Ngaphezu kwalokho, ukuthunyelwa kwemishini ye-ultrasound yokucabanga (ama- $ 340 million) kanye ne-x- Imishini ye-ray ($ 330 million) yaqhubeka ikhula, ikakhulukazi e-US naseChina.
Isikhathi sePosi: Aug-23-2022